Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 907.4 DKK -0.75% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Novo Nordisk A/S?
Write Note

Novo Nordisk A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novo Nordisk A/S
Revenue Peer Comparison

Comparables:
HLUN A
ALK B
S
STENO

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Novo Nordisk A/S
CSE:NOVO B
Revenue
kr244.2B
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
11%
H Lundbeck A/S
CSE:HLUN A
Revenue
kr19.9B
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Revenue
kr4.8B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
S
Stenocare A/S
CSE:STENO
Revenue
kr3.8m
CAGR 3-Years
167%
CAGR 5-Years
-2%
CAGR 10-Years
N/A

See Also

What is Novo Nordisk A/S's Revenue?
Revenue
244.2B DKK

Based on the financial report for Mar 31, 2024, Novo Nordisk A/S's Revenue amounts to 244.2B DKK.

What is Novo Nordisk A/S's Revenue growth rate?
Revenue CAGR 10Y
11%

Over the last year, the Revenue growth was 30%. The average annual Revenue growth rates for Novo Nordisk A/S have been 24% over the past three years , 16% over the past five years , and 11% over the past ten years .

Back to Top